The Academy's 2016 CECI2 Class



Dr. Gade’s research broadly focuses on the study of the tumor microenvironment and how alterations in the tumor microenvironment affect subpopulations of cancer cells, as well as how they influence the interactions of stromal cells with the tumor. As a resident, Dr. Gade founded the Penn Image-Guided Interventions Laboratory and developed a research team therein. He developed an independent research program resulting in ground breaking publications, successfully competed for internal and external foundation grants, and was the first radiologist to receive the prestigious NIH Director’s Early Independence Award. In his studies of cellular adaptations to ischemic stress, Dr. Gade has achieved the rare feat of bench-to-bedside translation as his findings have led to an IRB-approved clinical trial investigating combination therapy with transarterial chemoembolization (TACE) and autophagy inhibition in patients with hepatocellular carcinoma (HCC).








